Pattern-recognition receptors and immune effectors engaged by hepatitis B vaccine antigens

This target refers to the collective network of innate immune sensors and downstream adaptive immune components that are activated by Hepatitis B virus (HBV) vaccine antigens, primarily the Hepatitis B surface antigen (HBsAg). Innate recognition is mediated by pattern-recognition receptors (PRRs), including Toll-like receptors such as TLR9 (engaged by CpG adjuvants) and TLR4 (engaged by monophosphoryl lipid A), as well as the NLRP3 inflammasome which is activated by aluminum-based adjuvants (Source: NIH, MDPI). Engagement of these receptors triggers intracellular signaling cascades involving adapter proteins like MyD88 and transcription factors like NF-κB, leading to the secretion of pro-inflammatory cytokines and the maturation of antigen-presenting cells (Source: Frontiers in Immunology). These matured cells then present vaccine antigens to T and B lymphocytes, initiating the adaptive immune response characterized by the production of protective anti-HBs antibodies and the establishment of immunological memory (Source: PNAS). This coordinated response is the biological basis for the high efficacy of prophylactic HBV vaccines and remains a key area of research for developing therapeutic vaccines to treat chronic hepatitis B infection (Source: Annual Reviews).

Other names

Innate immune sensors of HBV vaccinesHBV vaccine-induced immune response componentsHBsAg-PRR interaction complexToll-like receptor signaling in HBV vaccinationAdjuvant-receptor engagement in hepatitis B immunization

Activation of innate immune sensors (PRRs) to induce cytokine production and dendritic cell maturation, bridging to the production of HBsAg-specific antibodies and T-cell responses.